Michelle Mitchell, Chief Executive at Cancer Research UK (CRUK), shared Cancer Research UK Science and Innovation’s post on LinkedIn, adding:
“Many thanks to Charlie for his insight and leadership over the past nine years. He helped guide Cancer Research UK (CRUK)‘s research agenda through some critical moments and it has been a pleasure working with him!”
Quoting Cancer Research UK Science and Innovation on LinkedIn:
“After nine years in the role, Professor Charles Swanton has stepped down as our chief clinician.
We thank him for his outstanding contribution in the role.
Charles’ scientific vision and leadership have shaped our clinical and translational research agenda throughout his tenure, championing the role of clinician scientists in cancer research and shaping their training and career path.
To mark the end of his term, we caught up with Charles to talk about the connection between the clinic and discovery research, and progress in our understanding of tumour heterogeneity and cancer evolution.”
Other articles featuring Michelle Mitchell and Cancer Research UK Science and Innovation on OncoDaily.